These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 2301388

  • 1. Recombinant human erythropoietin: 18 months' experience in hemodialysis patients.
    Canaud B, Polito-Bouloux C, Garred LJ, Rivory JP, Donnadieu P, Taib J, Florence P, Mion C.
    Am J Kidney Dis; 1990 Feb; 15(2):169-75. PubMed ID: 2301388
    [Abstract] [Full Text] [Related]

  • 2. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B, Polito-Bouloux C, Rivory JP, Donnadieu P, Taib J, Florence P, Mion C.
    Nephrologie; 1990 Feb; 11(1):5-10. PubMed ID: 2374643
    [Abstract] [Full Text] [Related]

  • 3. Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin.
    Tarng DC, Huang TP, Doong TI.
    Nephron; 1998 Feb; 78(3):253-9. PubMed ID: 9546682
    [Abstract] [Full Text] [Related]

  • 4. Erythropoietin-induced changes in protein nutrition: quantitative assessment by urea kinetic modeling analysis.
    Canaud B, Bouloux C, Rivory JP, Taib J, Garred LJ, Florence P, Mion C.
    Blood Purif; 1990 Feb; 8(5):301-8. PubMed ID: 2091690
    [Abstract] [Full Text] [Related]

  • 5. [The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial].
    Chen N, Qian JQ, Mei CL, Zhang AH, Xing CY, Wang L, Liu WH, Wang M, Chen JH, Liu BC, Hou FF, Chen XM, Zuo L, Shi W, Yu LB, Zhang Y.
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):502-7. PubMed ID: 22943819
    [Abstract] [Full Text] [Related]

  • 6. [The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials].
    Pljesa S.
    Med Pregl; 2007 Jul; 60(3-4):123-7. PubMed ID: 17853722
    [Abstract] [Full Text] [Related]

  • 7. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF, Casanova-González M, García-García I, Porrero-Martín PJ, Valenzuela-Silva CM, Hernández-Montero T, Lagarde-Ampudia M, Casanova-Kutsareva Y, Avila-Albuerne Y, Vargas-Batista A, Bobillo-López H, Herrera-Valdés R, López-Saura PA, Bioequivalence Study of Erythropoietin Group.
    BMC Nephrol; 2005 May 23; 6():5. PubMed ID: 15910687
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC, Lai YH, Tsai ZY, Chien LJ, Tsai JH.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar 23; 7(3):126-35. PubMed ID: 1865507
    [Abstract] [Full Text] [Related]

  • 9. Anemia Evaluation and Erythropoietin Dose Requirement Among Hemodialysis Patients: a Multicenter Study.
    Nafar M, Samavat S, Khoshdel A, Alipour-Abedi B.
    Iran J Kidney Dis; 2017 Jan 23; 11(1):56-65. PubMed ID: 28174354
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study of the efficacy of different regimens of intermittent subcutaneous dosing of erythropoietin beta in treatment of renal anemia in chronic dialysis patients].
    Nesić V, Ostrić V, Kovacević Z, Dimković N, Curić S, Lazarević M, Ratković M, Bogdanović J, Jelacić R.
    Med Pregl; 2005 Jan 23; 58(5-6):279-85. PubMed ID: 16526235
    [Abstract] [Full Text] [Related]

  • 11. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr 23; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 12. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM, Kuerner B, Zech M, Denninger G, Borneff C, Heidland A.
    Int J Artif Organs; 1988 Jul 23; 11(4):249-54. PubMed ID: 3410565
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy].
    Eiselt J, Veselá E, Racek J.
    Vnitr Lek; 1994 Jul 23; 40(7):437-9. PubMed ID: 8073661
    [Abstract] [Full Text] [Related]

  • 14. Erythropoietin response and route of administration.
    Taylor JE, Belch JJ, Fleming LW, Mactier RA, Henderson IS, Stewart WK.
    Clin Nephrol; 1994 May 23; 41(5):297-302. PubMed ID: 8050210
    [Abstract] [Full Text] [Related]

  • 15. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A.
    Cochrane Database Syst Rev; 2002 May 23; (4):CD003895. PubMed ID: 12519614
    [Abstract] [Full Text] [Related]

  • 16. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
    Boratyńska M, Szewczyk Z, Szepietowski T, Czyz W, Cybulski K, Bogucki J, Szczepański J.
    Przegl Lek; 1990 May 23; 47(11):741-5. PubMed ID: 2098840
    [Abstract] [Full Text] [Related]

  • 17. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C, Blumberg A.
    Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110
    [Abstract] [Full Text] [Related]

  • 18. [Effect of using recombinant human erythropoietin on the effectiveness of hemodialysis in children with terminal renal failure].
    Pietrzyk JA, Dyras P, Smolnik T, Szymowska M.
    Przegl Lek; 1992 Feb 17; 49(1-2):61-5. PubMed ID: 1280842
    [Abstract] [Full Text] [Related]

  • 19. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun 17; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A, Di Liberato L, Daniele F, Battistel V, Colombi L.
    Int J Artif Organs; 1998 Jan 17; 21(1):12-8. PubMed ID: 9554820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.